Topic prioritisation
Showing 1 to 2 of 2
| Title | Prioritisation routing | Decision | Decision date |
|---|---|---|---|
| Budesonide–glycopyrronium–formoterol fumarate for treating severe asthma in people 12 years and over TS ID 12018 | None selected | Not selected | |
| Dupilumab for maintenance treatment of uncontrolled moderate to severe asthma in children 6 to 11 years [TSID10085] | None selected | Not selected |